首頁 > 市場調查報告書 > 製藥

循環系統

主動脈瘤市場規模、佔有率和成長分析（按類型、治療方法、產品、最終用途和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1896071

主動脈瘤市場規模、佔有率和成長分析（按類型、治療方法、產品、最終用途和地區分類）—產業預測（2026-2033 年）

Aortic Aneurysm Market Size, Share, and Growth Analysis, By Type (Thoracic Aortic Aneurysm (TAA), Abdominal Aortic Aneurysm (AAA)), By Treatment, By Product, By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球主動脈瘤市場規模將達到 45.2 億美元，到 2025 年將達到 49.6 億美元，到 2033 年將達到 104.8 億美元，預測期（2026-2033 年）的複合年成長率為 9.8%。

全球主動脈瘤市場受到人口老化和動脈粥狀硬化盛行率上升的顯著影響。有利的醫療報銷政策推動了微創手術需求的激增。心血管疾病發生率上升、久坐不動的生活方式和不健康的飲食習慣等因素導致主動脈瘤發生率不斷攀升。患者族群日益壯大，尤其是在已開發國家，這些國家65歲以上人口的比例很高。吸煙等風險因素進一步增加了動脈瘤發生的可能性。此外，微創技術（例如血管內動脈瘤修復術 (EVAR)）的興起正在改變治療方法，帶來縮短恢復時間和改善患者預後等益處，從而推動市場成長。

全球主動脈瘤市場促進因素

全球主動脈瘤市場需求成長主要受該疾病發生率上升的驅動，尤其是在老年人。高血壓、吸菸和動脈粥狀硬化等因素共同導致主動脈瘤盛行率上升，對先進的診斷和治療方案產生了強烈的需求。為了有效應對這一嚴重的健康問題，醫療服務提供者正在積極尋求創新工具和治療方法。這一趨勢凸顯了將主動脈瘤治療作為醫療保健領域重點發展方向的重要性，從而推動了市場擴張以及對研發和技術的投資。

限制全球主動脈瘤市場的因素

全球主動脈瘤市場面臨的一大挑戰是公眾和醫療服務提供者對該疾病的認知不足。這種知識鴻溝會導致漏診和延誤治療，最終導致患者預後不佳。由於主動脈瘤的有效治療依賴於及時診斷和治療，這些因素會顯著阻礙市場成長和發展。提高公眾對疾病的認知和教育對於改善患者照護和推動市場發展至關重要。

全球主動脈瘤市場趨勢

全球主動脈瘤市場正呈現出顯著的發展趨勢，包括人口老化和心血管疾病盛行率上升，這些因素推動了對先進診斷和治療方案的需求。微創手術技術和血管內動脈瘤修復術（EVAR）的創新正在改善患者預後並縮短復原時間，進一步促進市場成長。此外，人工智慧（AI）和遠端醫療在患者管理中的應用提高了診斷準確性並實現了個人化治療。由於醫療專業人員和患者都優先考慮高效有效的解決方案，預計市場將持續擴張，這也凸顯了該關鍵領域持續研發的必要性。

Medtronic（USA）
WL Gore & Associates, Inc.（USA）
Cook Medical（USA）
Terumo Corporation（Japan）
Cardinal Health（USA）
Endologix, LLC（USA）
Lombard Medical（UK）
CryoLife, Inc.（USA）
MicroPort Scientific Corporation（China）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Becton, Dickinson and Company（USA）
Braun Melsungen AG（Germany）
Getinge AB（Sweden）
Merit Medical Systems, Inc.（USA）
Terumo Aortic（UK）
Biotronik SE & Co. KG（Germany）
Medtronic Vascular, Inc.（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2601

Global Aortic Aneurysm Market size was valued at USD 4.52 Billion in 2024 and is poised to grow from USD 4.96 Billion in 2025 to USD 10.48 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The global aortic aneurysm market is significantly influenced by the growing elderly population and the rising prevalence of atherosclerosis. The demand for minimally invasive procedures is surging, supported by favorable health reimbursement policies. Factors such as an increase in cardiovascular diseases, sedentary lifestyles, and poor dietary habits contribute to the rising incidence of aortic aneurysms. With a considerable percentage of the population aged over 65, the patient demographic is expanding, particularly in developed nations. Risk factors like smoking further heighten the likelihood of aneurysm development. Additionally, the shift towards minimally invasive techniques, such as endovascular aneurysm repair (EVAR), is transforming treatment approaches, offering benefits like reduced recovery time and improved patient outcomes, thus fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Aneurysm Market Segments Analysis

Global Aortic Aneurysm Market is segmented by Type, Treatment, Product, End-Use and region. Based on Type, the market is segmented into Thoracic Aortic Aneurysm (TAA) and Abdominal Aortic Aneurysm (AAA). Based on Treatment, the market is segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). Based on Product, the market is segmented into Stent Grafts, Catheters and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Aneurysm Market

The global market for aortic aneurysms is propelled by the growing occurrence of this condition, especially among older adults. Contributing elements like high blood pressure, tobacco use, and atherosclerosis are leading to a higher prevalence of aortic aneurysms, which in turn creates a strong demand for advanced diagnostic and therapeutic solutions. As the need for effective management of this serious health issue intensifies, healthcare providers are seeking innovative tools and treatments. This trend underscores the importance of addressing aortic aneurysms as a critical area for development within the medical field, driving market expansion and investment in research and technology.

Restraints in the Global Aortic Aneurysm Market

A major challenge facing the global aortic aneurysm market is the insufficient awareness regarding this condition among both the general public and healthcare providers. This knowledge gap can lead to a higher incidence of underdiagnosis and delayed medical intervention, ultimately contributing to adverse patient outcomes. Such factors can significantly impede the growth and development of the market, as effective management of aortic aneurysms is contingent upon timely diagnosis and treatment. Enhancing awareness and education around this condition is essential for improving patient care and driving the market forward.

Market Trends of the Global Aortic Aneurysm Market

The Global Aortic Aneurysm market is witnessing a notable trend characterized by an increasing demand for advanced diagnostic and therapeutic options driven by a growing aging population and the rising prevalence of cardiovascular diseases. Innovations in minimally invasive surgical techniques and endovascular aneurysm repair (EVAR) are enhancing patient outcomes while reducing recovery times, further propelling market growth. Additionally, the integration of artificial intelligence and telemedicine into patient management is improving diagnosis accuracy and treatment personalization. As healthcare professionals and patients alike prioritize efficient and effective solutions, the market is positioned for continued expansion, emphasizing the need for ongoing research and development in this critical area.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape
Patent Analysis

Global Aortic Aneurysm Market Size by Type & CAGR (2026-2033)

Market Overview
Thoracic Aortic Aneurysm (TAA)
Abdominal Aortic Aneurysm (AAA)

Global Aortic Aneurysm Market Size by Treatment & CAGR (2026-2033)

Market Overview
Open Surgical Repair (OSR)
Endovascular Aneurysm Repair (EVAR)

Global Aortic Aneurysm Market Size by Product & CAGR (2026-2033)

Market Overview
Stent Grafts
Catheters
Others

Global Aortic Aneurysm Market Size by End-Use & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgery Centers (ASCs)
Others

Global Aortic Aneurysm Market Size & CAGR (2026-2033)

North America (Type, Treatment, Product, End-Use)
- US
- Canada
Europe (Type, Treatment, Product, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Treatment, Product, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Treatment, Product, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Treatment, Product, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W.L. Gore & Associates, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lombard Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Aortic (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Vascular, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments